Pancreatic Cancer Research

ResearcherUniversity of PittsburghNo recent work listed

Dexing Zeng

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-4948-5275; OpenAlex author ID A5064525591; NIH RePORTER profile ID 11288938. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
1
Labs led
1
Collaborators
8
Papers, trials and grants by year

2014: 1 grant · 2015: none · 2016: none · 2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper

Papers 2

  1. Heterodimeric RGD-NGR PET Tracer for the Early Detection of Pancreatic Cancer. Last author DOI 10.1007/s11307-022-01704-6↗
  2. Intracellular HMGB1 as a novel tumor suppressor of pancreatic cancer. Co-author DOI 10.1038/cr.2017.51↗

Grants 1

  1. Solid-Phase Platform for the Preparation of Dual-receptor Targeted PET Agents R21EB017317↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Rui Kang · 2 shared papers, 2017–2022 · strength 0.22
  2. Daolin Tang · 2 shared papers, 2017–2022 · strength 0.22
  3. Yongkang Gai · 1 shared paper, 2022 · strength 0.16
  4. Lingyi Sun · 1 shared paper, 2022 · strength 0.16
  5. Yangchun Xie · 1 shared paper, 2017 · strength 0.06
  6. Herbert J. Zeh · 1 shared paper, 2017 · strength 0.06
  7. David L. Bartlett · 1 shared paper, 2017 · strength 0.06
  8. Michael T. Lotze · 1 shared paper, 2017 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.